Clinical Research Directory
Browse clinical research sites, groups, and studies.
TULIP ReTrain Study
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Summary
This prospective clinical study aims to retrain and validate the PCaVision AI algorithm for the detection and localization of clinically significant prostate cancer (csPCa) using multiparametric ultrasound (mpUS) with two different ultrasound contrast agents: Sonovue and Optison. Data will be collected using a commercial version of the LOGIQ E10 ultrasound machine, with full histopathological correlation in patients undergoing radical prostatectomy.
Official title: Optimization of PCaVision: A Prospective Study for CAD-based Detection of Clinically Significant Prostate Cancer Using mpUS and Contrast Agents
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
212
Start Date
2025-07
Completion Date
2026-12
Last Updated
2025-05-16
Healthy Volunteers
No
Conditions
Interventions
Multiparametric ultrasound with contrast (Sonovue and Optison)
Participants will receive 3D mpUS using both Sonovue and Optison contrast agents during a single transrectal imaging session.
Locations (1)
Amsterdam UMC
Amsterdam, Netherlands